PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.20%
Revenue growth at 75-90% of LSCC's 5.97%. Bill Ackman would push for innovation or market expansion to catch up.
-6.44%
Negative gross profit growth while LSCC is at 6.31%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.41%
Negative EBIT growth while LSCC is at 10.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.41%
Negative operating income growth while LSCC is at 10.00%. Joel Greenblatt would press for urgent turnaround measures.
0.69%
Net income growth under 50% of LSCC's 13.27%. Michael Burry would suspect the firm is falling well behind a key competitor.
-5.26%
Negative EPS growth while LSCC is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.26%
Negative diluted EPS growth while LSCC is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.57%
Share reduction more than 1.5x LSCC's 12.94%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.27%
Reduced diluted shares while LSCC is at 12.94%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.54%
Dividend growth of 2.54% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
4.31%
OCF growth under 50% of LSCC's 19.53%. Michael Burry might suspect questionable revenue recognition or rising costs.
-94.07%
Negative FCF growth while LSCC is at 21.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
137.93%
10Y revenue/share CAGR under 50% of LSCC's 477.58%. Michael Burry would suspect a lasting competitive disadvantage.
76.91%
5Y revenue/share CAGR under 50% of LSCC's 171.34%. Michael Burry would suspect a significant competitive gap or product weakness.
71.38%
3Y revenue/share CAGR above 1.5x LSCC's 45.75%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
-9.01%
Negative 5Y OCF/share CAGR while LSCC is at 314.58%. Joel Greenblatt would question the firm’s operational model or cost structure.
42.84%
3Y OCF/share CAGR above 1.5x LSCC's 21.87%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
665.18%
10Y net income/share CAGR of 665.18% while LSCC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
548.82%
5Y net income/share CAGR above 1.5x LSCC's 321.08%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
257.19%
3Y net income/share CAGR above 1.5x LSCC's 86.44%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
128.96%
Equity/share CAGR of 128.96% while LSCC is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
49.99%
Below 50% of LSCC's 253.65%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
98.79%
3Y equity/share CAGR at 50-75% of LSCC's 141.81%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
4.56%
Dividend/share CAGR of 4.56% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
23.92%
Dividend/share CAGR of 23.92% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.96%
3Y dividend/share CAGR of 29.96% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.71%
Firm’s AR is declining while LSCC shows 14.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.77%
Inventory growth well above LSCC's 9.00%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.61%
Asset growth well under 50% of LSCC's 45.84%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.79%
Under 50% of LSCC's 35.57%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.21%
We’re deleveraging while LSCC stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while LSCC invests at 1.49%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
40.00%
SG&A growth well above LSCC's 3.90%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.